ThumarJaykumarMD

Oncology • Enfield, CT

Gastrointestinal Cancer, Hematologic Oncology

Physician

Join to view full profile

Dr. Jaykumar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jaykumar's full profile

Already have an account?

Office
140 Hazard Avenue
Enfield, CT 06082
Phone+1 860-272-2911

Fax+1 860-684-6550

Education & Training

Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
University of ConnecticutInternship, Internal Medicine, 2005 - 2009
B. J. Medical College AhmedabadClass of 1996

Certifications & Licensure

American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Scholarship in Medicine� award University of Connecticut, 2008
Chief Resident University of Connecticut, 2008

Publications & Presentations

Journal Articles

MEK targeting in N-RAS mutated metastatic melanoma
Thumar J, Shahbazian D, Aziz SA, Jilaveanu LB, Kluger HM, Mol Cancer., 1/4/2014
FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity
Gunturu KS, Yao X, Cong X, Thumar JR, Hochster HS, Stein SM, Lacy J, Med Oncol, 1/1/2013
Drug targets and predictive biomarkers in the management of metastatic melanoma
Thumar J, Giesen E, Kluger HM, Pharmgenomics Pers Med, 1/1/2012
Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
Deshpande H, Roman S, Thumar J, Sosa JA, Clin Med Insights Oncol., 1/1/2011
Ipilimumab: a promising immunotherapy for melanoma
Thumar JR, Kluger HM, Oncology (Williston Park), 1/1/2010
Differential Protein Expression Profiles in Estrogen Receptor-Positive and -Negative Breast Cancer Tissues Using Label-Free Quantitative Proteomics
Karim Rezaul, Jay Kumar Thumar, Deborah H. Lundgren, Jimmy K. Eng, Kevin P. Claffey, Lori Wilson and David K, Ha. Genes & Cancer, 1/1/2010
Direct cancer tissue proteomics: a method to identify candidate cancer biomarkers from formalin-fixed paraffin-embedded archival tissues
Hwang SI, Thumar J, Lundgren DH, Rezaul K, Mayya V, Wu L, Eng J, Wright ME, Han DK, Oncogene, 1/4/2007
Proteomics analysis of human coronary atherosclerotic plaque: a feasibility study of direct tissue proteomics by liquid chromatography and tandem mass spectrometry
Bagnato C, Thumar J, Mayya V, Hwang SI, Zebroski H, Claffey KP, Haudenschild C, Eng JK, Lundgren DH, Han DK, Mol Cell Proteomics, 1/1/2007
Identification of putative androgen receptor interaction protein modules: cytoskeleton and endosomes modulate androgen receptor signaling in prostate cancer cells
Jasavala R, Martinez H, Thumar J, Andaya A, Gingras AC, Eng JK, Aebersold R, Han DK, Wright ME, Mol Cell Proteomics, 1/1/2007
Join now to see all

Abstracts/Posters

Anemia in advanced cancer treated with chemotherapy.
Thumar J, Bansal R, Zaeem F, American Collage of Physicians, Annual meeting, Connecticut chapter, Southington, CT, 1/1/2007
Clostridium Difficile Infection: What's New?
Thumar JR, Tandon H, Bansal R, Respicio G, American Collage of Physicians, Annual meeting, Southington, CT, 1/1/2006
Identification of New Markers of Disease Progression and Therapeutic Targets by Proteome Analysis of Human Coronary Artery Atherosclerotic Lesions.
Bagnato C, Thumar JR, Han DK, American Society Mass spectrometry Annual meeting, St. Jose, TX, 1/1/2005
A proteomic analysis of prostate cancer tissues by direct cancer tissue proteomics.
Hwang S, Thumar JR, Lundgren DH, Rezaul KM, Eng J, Han DK, American Association of Cancer Research, Annual meeting, San Diego, CA, 1/1/2005
Proteomics in Medicine: Research Bridging Bench to Bed.
Thumar J, Bagnato C, Han DK, American Collage of Physicians, Annual meeting, Southington, CT, 1/1/2005
Join now to see all